Filing Details
- Accession Number:
- 0001127602-24-025334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-08 16:27:31
- Reporting Period:
- 2024-10-03
- Accepted Time:
- 2024-10-08 16:27:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1830214 | Ginkgo Bioworks Holdings Inc. | DNA | Biological Products, (No Disgnostic Substances) (2836) | 872652913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1977441 | P. Steven Coen | C/O Ginkgo Bioworks Holdings, Inc. 27 Drydock Avenue Boston MA 02210 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-10-03 | 587 | $0.00 | 6,196 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-10-03 | 156 | $0.00 | 6,352 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-10-04 | 306 | $8.35 | 6,046 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Restricted Stock Units | Disposition | 2024-10-03 | 587 | $0.00 | 587 | $0.00 |
| Class A Common Stock | Restricted Stock Units | Disposition | 2024-10-03 | 156 | $0.00 | 156 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,210 | No | 4 | M | Direct | ||
| 6,407 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with thevesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover"transaction.
- The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
- The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.
Billionaire Hedge Funds
